Abstract
Background: Functional imaging with 68Ga-DOTATATE PET-CT is widely employed to detect both primary and metastatic pheochromocytomas and paragangliomas (PGL), but its results may be occasionally misleading as in the case here reported.
Case Presentation: We report here a 75-year-old woman with an interaortocaval PGL that was diagnosed after a hypertensive crisis occurring during the resection of a kidney tumor. 68Ga-DOTATATE PET-CT disclosed pathologic uptake in the abdomen and at the iliac crest. After the resection of the abdominal tumor, with the histological confirmation of PGL, arterial blood pressure and metanephrine levels were normalized. Genetic testing was negative. Thereafter, the bone lesion increased in size and became painful, requiring multiple medications. A selective biopsy disclosed a metastatic lesion arising from the renal tumor.
Conclusion: The false-positive result of 68Ga-DOTATATE PET-CT is discussed.
Keywords: Paraganglioma, pheochromocytoma, imaging, Ga-DOTA-peptides, bone metastasis, differential diagnosis.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:False Positive of 68Ga-DOTATATE PET-CT in a Paraganglioma
Volume: 21 Issue: 7
Author(s): Benedetta Zampetti, Roberto Attanasio*, Marco Boniardi and Renato Cozzi
Affiliation:
- IRCCS Orthopedic Institute Galeazzi, Endocrinology Service, Milan,Italy
Keywords: Paraganglioma, pheochromocytoma, imaging, Ga-DOTA-peptides, bone metastasis, differential diagnosis.
Abstract:
Background: Functional imaging with 68Ga-DOTATATE PET-CT is widely employed to detect both primary and metastatic pheochromocytomas and paragangliomas (PGL), but its results may be occasionally misleading as in the case here reported.
Case Presentation: We report here a 75-year-old woman with an interaortocaval PGL that was diagnosed after a hypertensive crisis occurring during the resection of a kidney tumor. 68Ga-DOTATATE PET-CT disclosed pathologic uptake in the abdomen and at the iliac crest. After the resection of the abdominal tumor, with the histological confirmation of PGL, arterial blood pressure and metanephrine levels were normalized. Genetic testing was negative. Thereafter, the bone lesion increased in size and became painful, requiring multiple medications. A selective biopsy disclosed a metastatic lesion arising from the renal tumor.
Conclusion: The false-positive result of 68Ga-DOTATATE PET-CT is discussed.
Export Options
About this article
Cite this article as:
Zampetti Benedetta , Attanasio Roberto *, Boniardi Marco and Cozzi Renato, False Positive of 68Ga-DOTATATE PET-CT in a Paraganglioma, Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21 (7) . https://dx.doi.org/10.2174/1871530320666200821141256
DOI https://dx.doi.org/10.2174/1871530320666200821141256 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mesenchymal Stem Cells for Anti-Cancer Drug Delivery
Recent Patents on Anti-Cancer Drug Discovery Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer
Current Drug Targets Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety
Current Medicinal Chemistry Therapeutic Value of an Integrin Antagonist in Prostate Cancer
Current Drug Targets Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry Immunotherapy Approaches in Cancer Treatment
Current Pharmaceutical Biotechnology Glioblastoma Multiforme Formation and EMT: Role of FoxM1 Transcription Factor
Current Pharmaceutical Design Molecular Mechanisms of Anti-cancer Action of Garlic Compounds in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry In Silico Analysis of Plasmodium Falciparumenolase and Human Plasminogen Interaction: Implications for Transmission blocking of the Parasite
Letters in Drug Design & Discovery The University of New Mexico Center for Molecular Discovery
Combinatorial Chemistry & High Throughput Screening History and Evolution of Reproductive and Developmental Toxicology Guidelines
Current Pharmaceutical Design PARP Inhibitor Development for Systemic Cancer Targeting
Anti-Cancer Agents in Medicinal Chemistry Nanoparticles-Based Treatment for Bone Metastasis
Current Drug Targets Biodegradable Nanoparticles: A Recent Approach and Applications
Current Drug Targets Fatty Acid-Binding Proteins at a Glance
Protein & Peptide Letters Revisiting Non-Cancer Drugs for Cancer Therapy
Current Topics in Medicinal Chemistry Design and Development of Nanovehicle-Based Delivery Systems for Preventive or Therapeutic Supplementation with Flavonoids
Current Medicinal Chemistry Interferon Therapy in Lung Cancer: Current Perspectives
Current Cancer Therapy Reviews Core-shell Semiconductor Nanocrystals: Effect of Composition, Size, Surface Coatings on their Optical Properties, Toxicity and Pharmacokinetics
Current Pharmaceutical Design Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Current Medicinal Chemistry